Cash & equivalents increased 17.7%
Cash & equivalents changed +17.7% from the comparable as-filed period.
$1.5B→$1.8B3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ALNY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation decreased 26.9%
Stock-based compensation changed -26.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$108.2M→$79.1M2 prior comparisons
Capital expenditure increased 475.1%
Capital expenditure changed +475.1% from the comparable as-filed period.
$12.1M→$69.8M2 prior comparisons
Receivables / revenue moved 284 bp lower
Receivables / revenue changed -284 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
77.24%→74.41%2 prior comparisons
Operating income decreased 6.0%
Operating income changed -6.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$368.0M→$345.8M2 prior comparisons
Free-cash-flow proxy decreased 13.4%
Free-cash-flow proxy changed -13.4% from the comparable as-filed period.
$313.0M→$271.2M2 prior comparisons
Inventory / revenue moved 123 bp higher
Inventory / revenue changed +123 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.04%→7.26%2 prior comparisons
Research & development increased 13.9%
Research & development changed +13.9% from the comparable as-filed period.
$358.8M→$408.5M2 prior comparisons
Free-cash-flow margin moved 646 bp lower
Free-cash-flow margin changed -646 basis points from the comparable as-filed period.
25.06%→18.60%2 prior comparisons
Operating cash flow increased 4.9%
Operating cash flow changed +4.9% from the comparable as-filed period.
$325.1M→$341.0M2 prior comparisons
Operating cash-flow margin moved 264 bp lower
Operating cash-flow margin changed -264 basis points from the comparable as-filed period.
26.03%→23.39%2 prior comparisons
Trade receivables increased 12.5%
Trade receivables changed +12.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$964.8M→$1.1B4 prior comparisons
Shares outstanding increased 1.4%
Shares outstanding changed +1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
132,113,818→133,937,5768 prior comparisons
Selling, general & administrative increased 6.2%
Selling, general & administrative changed +6.2% from the comparable as-filed period.
$322.1M→$342.0M2 prior comparisons
R&D / revenue moved 71 bp lower
R&D / revenue changed -71 basis points from the comparable as-filed period.
28.73%→28.02%2 prior comparisons
Current ratio decreased 2.5%
Current ratio changed -2.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
2.54→2.484 prior comparisons
Total assets increased 21.7%
Total assets changed +21.7% from the comparable as-filed period.
$4.6B→$5.6B3 prior comparisons
Inventory increased 35.5%
Inventory changed +35.5% from the comparable as-filed period.
$71.7M→$97.1M3 prior comparisons
R&D / revenue moved 983 bp lower
R&D / revenue changed -983 basis points from the comparable as-filed period.
41.83%→32.00%2 prior comparisons
Stock-based compensation decreased 22.4%
Stock-based compensation changed -22.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$111.7M→$86.6M2 prior comparisons
Receivables / revenue moved 260 bp lower
Receivables / revenue changed -260 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
73.30%→70.70%2 prior comparisons
Current liabilities increased 16.3%
Current liabilities changed +16.3% from the comparable as-filed period.
$1.3B→$1.5B3 prior comparisons
Inventory / revenue moved 174 bp lower
Inventory / revenue changed -174 basis points from the comparable as-filed period.
9.27%→7.52%2 prior comparisons
Working capital / assets moved 459 bp higher
Working capital / assets changed +459 basis points from the comparable as-filed period.
51.31%→55.91%3 prior comparisons
Current ratio increased 9.1%
Current ratio changed +9.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
2.8→3.053 prior comparisons
Shares outstanding increased 2.1%
Shares outstanding changed +2.1% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
131,079,015→133,809,1188 prior comparisons
Selling, general & administrative increased 7.6%
Selling, general & administrative changed +7.6% from the comparable as-filed period.
$323.3M→$347.9M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.